These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 8066357)
41. [Hypercholesterolemia and hypertension--equivalent risk factors?]. Kaufmann G Schweiz Rundsch Med Prax; 1991 Nov; 80(46):1272-7. PubMed ID: 1957090 [TBL] [Abstract][Full Text] [Related]
42. [Benefits and costs of early detection and treatment of hypercholesterolemia]. Laaser U Z Kardiol; 1994; 83 Suppl 6():163-7. PubMed ID: 7863690 [TBL] [Abstract][Full Text] [Related]
43. [Which study conclusions favor so-called primary prevention of increased cholesterol values, which speak against prevention and what therapy guidelines are reliable?]. Steinmetz A Internist (Berl); 1994 Sep; 35(9):880-1. PubMed ID: 7960571 [No Abstract] [Full Text] [Related]
45. [When should hypercholesterolemia patients be diagnosed and treated?]. Jacotot B Rev Prat; 1989 Apr; 39(12):1046-8. PubMed ID: 2740768 [TBL] [Abstract][Full Text] [Related]
46. [Cholesterol lowering and life expectancy: a critical evaluation]. Klepzig H; Kaltenbach M Z Kardiol; 1992 Jul; 81(7):347-53. PubMed ID: 1509792 [TBL] [Abstract][Full Text] [Related]
47. [The cholesterol question. Disinformed information]. Bobbio M; Brusca A G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828 [No Abstract] [Full Text] [Related]
48. Effect of garlic on serum lipids: an updated meta-analysis. Ried K; Toben C; Fakler P Nutr Rev; 2013 May; 71(5):282-99. PubMed ID: 23590705 [TBL] [Abstract][Full Text] [Related]
49. [Prevention of myocardial infarction by reducing serum cholesterol levels. High-risk strategies should be limited]. Jacobsen BK Tidsskr Nor Laegeforen; 1991 Jun; 111(17):2159-61. PubMed ID: 1871755 [TBL] [Abstract][Full Text] [Related]
50. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention. Labreche DG Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850 [No Abstract] [Full Text] [Related]
52. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood. Nelemans FA Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745 [No Abstract] [Full Text] [Related]
53. Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program. Grundy SM; Cleeman JI; Rifkind BM; Kuller LH Arch Intern Med; 1999 Aug 9-23; 159(15):1670-8. PubMed ID: 10448768 [TBL] [Abstract][Full Text] [Related]
54. [The modification of lipids in a secondary prevention program by general practice physicians]. Guistini S; Mandelli P; Bartoli U; Pastacaldi G; Pasticci C; Fronges D; Quattrocchi M Riv Eur Sci Med Farmacol; 1994; 16(1-2):7-11. PubMed ID: 7761683 [TBL] [Abstract][Full Text] [Related]
58. Strategies for optimizing treatment outcomes. Jones Freeman EL J Manag Care Pharm; 2003; 9(1 Suppl):20-3. PubMed ID: 14613356 [TBL] [Abstract][Full Text] [Related]
59. [In whom, when and how should increased cholesterol values be treated?]. Greten H Arzneimittelforschung; 1990 Mar; 40(3A):381-3. PubMed ID: 2185770 [TBL] [Abstract][Full Text] [Related]
60. Cholesterol and coronary heart disease. The attributable risk reduction of diet and drugs. Malenka DJ; Baron JA Arch Intern Med; 1989 Sep; 149(9):1981-5. PubMed ID: 2673117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]